Literature DB >> 25817725

Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.

Indira Tiwari1, Min-Ho Yoon2, Bum-Joon Park2, Kyung Lib Jang3.   

Abstract

Downregulation of E-cadherin is a hallmark of epithelial-mesenchymal transition (EMT), an essential component of cancer progression to more aggressive phenotypes characterized by tumor dedifferentiation, infiltration, and metastasis. However, the underlying mechanism for E-cadherin downregulation in hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) is still unclear. In this study, we found that ectopic expression of HCV core protein or infection with HCV in human hepatocytes upregulated the levels of the transcriptional repressors, E12 and E47, resulting in inactivation of the E-cadherin promoter, containing E-box motifs, and subsequent repression of its expression. E12/E47 knock-down almost completely abolished the potential of HCV core protein to repress E-cadherin expression. HCV core protein inhibited ubiquitin-dependent proteasomal degradation of E12/E47 without affecting their expression at the transcriptional level. E12/E47 upregulation ultimately led to EMT in human hepatocytes, as demonstrated by morphological changes, altered expression levels of EMT markers, including E-cadherin, plakoglobin, and fibronectin, and increased capacity for cell detachment and migration. In conclusion, HCV core protein represses E-cadherin expression by upregulating E12/E47 levels to induce EMT in HCV-associated HCC.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  E-cadherin; E12/E47; Epithelial–mesenchymal transition; Hepatitis C virus core protein; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2015        PMID: 25817725     DOI: 10.1016/j.canlet.2015.03.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.

Authors:  Takashi Yamazaki; Lizhi Liu; Denis Lazarev; Amr Al-Zain; Vitalay Fomin; Percy Luk Yeung; Stuart M Chambers; Chi-Wei Lu; Lorenz Studer; James L Manley
Journal:  Genes Dev       Date:  2018-08-16       Impact factor: 11.361

2.  Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation.

Authors:  Liat Ninio; Abraham Nissani; Tomer Meirson; Tom Domovitz; Alessandro Genna; Shams Twafra; Kolluru D Srikanth; Roba Dabour; Erez Avraham; Ateret Davidovich; Hava Gil-Henn; Meital Gal-Tanamy
Journal:  Cells       Date:  2019-11-05       Impact factor: 6.600

Review 3.  Crucial roles of different RNA-binding hnRNP proteins in Stem Cells.

Authors:  Wen Xie; Hecheng Zhu; Ming Zhao; Lei Wang; Shasha Li; Cong Zhao; Yao Zhou; Bin Zhu; Xingjun Jiang; Weidong Liu; Caiping Ren
Journal:  Int J Biol Sci       Date:  2021-02-08       Impact factor: 6.580

4.  Hepatitis C virus NS4B protein induces epithelial-mesenchymal transition by upregulation of Snail.

Authors:  Bicheng Hu; Shenggao Xie; Yuqian Hu; Wen Chen; Xiaofan Chen; Yi Zheng; Xinxing Wu
Journal:  Virol J       Date:  2017-04-21       Impact factor: 4.099

5.  BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.

Authors:  Xu-Xiao Chen; Yue Yin; Jian-Wen Cheng; Ao Huang; Bo Hu; Xin Zhang; Yun-Fan Sun; Jian Wang; Yu-Peng Wang; Yuan Ji; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xin-Rong Yang
Journal:  Cell Death Dis       Date:  2018-10-10       Impact factor: 8.469

6.  Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.

Authors:  Jianwei Lin; Yuchen Hou; Shanzhou Huang; Ziming Wang; Chengjun Sun; Zekang Wang; Xiaoshun He; Nga Lei Tam; Chenglin Wu; Linwei Wu
Journal:  Mol Carcinog       Date:  2018-11-14       Impact factor: 4.784

Review 7.  Impact of HCV Infection on Hepatocyte Polarity and Plasticity.

Authors:  Jean Agnetti; Christophe Desterke; Ama Gassama-Diagne
Journal:  Pathogens       Date:  2022-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.